Login

Consolidated Statements of Assets and Liabilities

In millions of USD, except per-share amounts
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Assets
Investments, at fair value
Non-controlled/non-affiliated investments (cost of $345,232 and $247,053)
Non-controlled affiliated investments (cost of $4,249 and $3,785)
Investment, Non-affiliated Issuer
Investment, Affiliated Issuer
Total investments, at fair value
Total investments, at fair value (cost of $882,016 and $856,852)
Investments in affiliated money market fund (cost of $4,006 and $9,506)
Investments in affiliated money market fund
Cash
Interest and dividends receivable
Deferred financing costs
Other assets
Total assets
Liabilities
Debt
Interest and other debt expenses payable
Management fees payable
Incentive fees based on income payable
Incentive fees based on capital gains payable
Distribution payable
Directors' fees payable
Accrued expenses and other liabilities
Total liabilities
Net assets
Preferred stock, par value $0.001 per share (1,000,000 shares authorized and no shares issued and outstanding)
Common stock, par value $0.001 per share (200,000,000 shares authorized, 23,959,371 and 23,959,371 shares issued and outstanding as of June 30, 2025 and December 31, 2024)
Paid-in capital in excess of par
Distributable earnings (loss)
Total net assets
Total liabilities and net assets
Net asset value per share

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support